TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α

Breast cancer is the most commonly diagnosed malignancy in female worldwide, over 70% of which are estrogen receptor α (ERα) positive. ERα has a crucial role in the initiation and progression of breast cancer and is an indicator of endocrine therapy, while endocrine resistance is an urgent problem i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Jianing, Luo, Yongwen, Tian, Zelin, Liao, Xing, Cui, Qiuxia, Yang, Qian, Wu, Gaosong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326724/
https://www.ncbi.nlm.nih.gov/pubmed/32599554
http://dx.doi.org/10.1016/j.neo.2020.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326724/
https://www.ncbi.nlm.nih.gov/pubmed/32599554
http://dx.doi.org/10.1016/j.neo.2020.06.003

Ejemplares similares